3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
35
Rectal Neoplasms
24
Stomach Neoplasms
19
Triple Negative Breast Neoplasms
16
Colorectal Neoplasms
14
Neoplasm Metastasis
12
Adenocarcinoma
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Nasopharyngeal Carcinoma
7
Adenocarcinoma Of Esophagus
7
Neoplasms
6
Colonic Neoplasms
6
Biliary Tract Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Pathologic Complete Response
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Locally Advanced Rectal Cancer
2
Carcinoma
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Resectable Colon Cancer
1
Rectal Cancer Patients
1
Interventions
apatinib
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastrectomy
2
trastuzumab deruxtecan
1
taxane
1
durvalumab
1
disitamab vedotin
1
Taxes
1
SHR-1701
1
S 1 (combination)
1
Platinum
1
Paclitaxel
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Indocyanine Green
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastric Adenocarcinoma
×
Capecitabine
×
90 days
×
Clear all
No trials found.